The trademark Symbiosia was filed by WELLMARK, a corporation established under the laws of the Swiss Confederation (the "Applicant"). The application was published for oppositions on June 19, 2023, and received one opposition filed on September 13, 2023 by SymbioPharm GmbH on Likelihood of confusion. the opponent was represented by KLEYMANN, KARPENSTEIN & PARTNER MBB and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued September 13, 2023
The application was filed in French, and French was also language of all opposition proceedings (English was selected as the second language).
The Opposition with reference B 003203294 was rejected according to Article 8(1)(b) EUTMR with decision issued on October 2, 2024 by the EUIPO.